[Drug interaction of antitumor drugs. II. Antitumor activity of cyclophosphamide in immunopotentiator-treated mice (author's transl)].
D000818:Animals; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors*; D001688:Biological Products / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D007109:Immunity / Q000187:drug effects; D008070:Lipopolysaccharides / Q000494:pharmacology*; D051379:Mice; D009161:Mycobacterium / Q000276:immunology*; D010844:Picibanil / Q000494:pharmacology*
D000970:Antineoplastic Agents; D001688:Biological Products; D008070:Lipopolysaccharides; D010844:Picibanil; D003520:Cyclophosphamide